Published in Clin Cancer Res on January 31, 2017
Implementing liquid biopsies into clinical decision making for cancer immunotherapy. Oncotarget (2017) 0.77
Non-coding RNA: It's Not Junk. Dig Dis Sci (2017) 0.75
Analysis of miR-96 and miR-133a Expression in Gastrointestinal Neuroendocrine Neoplasms. Endocr Pathol (2017) 0.75
Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma. J Int Med Res (2017) 0.75
Global cancer statistics, 2012. CA Cancer J Clin (2015) 53.52
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86
Epigenetics in human disease and prospects for epigenetic therapy. Nature (2004) 11.46
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A (2011) 10.56
Circulating mutant DNA to assess tumor dynamics. Nat Med (2007) 10.33
Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol (2008) 10.28
Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut (2009) 8.98
Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med (2014) 8.36
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol (2011) 8.21
Epigenetics in cancer. Carcinogenesis (2009) 7.49
Characterization of extracellular circulating microRNA. Nucleic Acids Res (2011) 6.24
MicroRNAs in body fluids--the mix of hormones and biomarkers. Nat Rev Clin Oncol (2011) 5.46
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature (2015) 5.15
Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res (2008) 4.95
Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol (2014) 4.76
Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. J Natl Cancer Inst (2013) 4.03
Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol (2011) 3.80
Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer (2010) 3.59
Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog (2010) 3.44
Liquid biopsy: monitoring cancer-genetics in the blood. Nat Rev Clin Oncol (2013) 3.34
Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol (2014) 2.87
Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res (2010) 2.85
A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer (2010) 2.84
MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls. Clin Cancer Res (2013) 2.71
Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol (2012) 2.62
Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem (2011) 2.42
Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels. Cancer Res (2010) 2.39
Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. Clin Chem (2010) 2.34
Sensitive digital quantification of DNA methylation in clinical samples. Nat Biotechnol (2009) 2.34
Markers for early detection of cancer: statistical guidelines for nested case-control studies. BMC Med Res Methodol (2002) 2.26
Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. Mol Cell Proteomics (2009) 2.08
A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer. Ann Surg (2013) 2.07
Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer (2011) 1.97
Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One (2014) 1.83
MicroRNA biomarkers in whole blood for detection of pancreatic cancer. JAMA (2014) 1.78
A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study. Lancet Oncol (2015) 1.76
Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening. Dig Dis Sci (2012) 1.76
Circulating microRNA biomarker studies: pitfalls and potential solutions. Clin Chem (2014) 1.71
Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. PLoS One (2012) 1.70
Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer. Int J Cancer (2011) 1.68
Tumor cell-derived exosomes: a message in a bottle. Biochim Biophys Acta (2012) 1.67
Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer. Cancer Prev Res (Phila) (2013) 1.66
Bioinformatics for protein biomarker panel classification: what is needed to bring biomarker panels into in vitro diagnostics? Expert Rev Proteomics (2009) 1.61
Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Br J Cancer (2013) 1.48
Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis. Nat Cell Biol (2015) 1.36
Esophageal cancer: staging system and guidelines for staging and treatment. J Thorac Dis (2014) 1.31
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers. Gastroenterology (2015) 1.24
Identification of a circulating microRNA signature for colorectal cancer detection. PLoS One (2014) 1.22
U6 is not a suitable endogenous control for the quantification of circulating microRNAs. Biochem Biophys Res Commun (2014) 1.21
Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancer. Br J Cancer (2014) 1.19
Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma. Br J Cancer (2014) 1.13
Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma. PLoS One (2014) 1.12
MicroRNAs in rheumatoid arthritis: altered expression and diagnostic potential. Autoimmun Rev (2015) 1.08
MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers. PLoS One (2015) 1.08
Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry. J Clin Epidemiol (2013) 1.05
Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer (2013) 1.05
Plasma microRNA profiles: identification of miR-25 as a novel diagnostic and monitoring biomarker in oesophageal squamous cell carcinoma. Br J Cancer (2014) 1.04
Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia. Clin Cancer Res (2015) 1.03
Circulating MicroRNA-21 Is a Potential Diagnostic Biomarker in Gastric Cancer. Dis Markers (2015) 1.01
Diagnosis and management of cholangiocarcinomas: a comprehensive review. Hepatogastroenterology (2004) 0.98
Circulating miR-222 in plasma and its potential diagnostic and prognostic value in gastric cancer. Med Oncol (2014) 0.96
Use of blood-based biomarkers for early diagnosis and surveillance of colorectal cancer. World J Gastrointest Oncol (2014) 0.96
Three dysregulated microRNAs in serum as novel biomarkers for gastric cancer screening. Med Oncol (2014) 0.90
Beyond the one-locus-one-miRNA paradigm: microRNA isoforms enable deeper insights into breast cancer heterogeneity. Nucleic Acids Res (2015) 0.89
What's new on circulating tumor cells? A meeting report. Breast Cancer Res (2010) 0.88
Emerging optical methods for surveillance of Barrett's oesophagus. Gut (2015) 0.88
Accessing Genetic Information with Liquid Biopsies. Trends Genet (2015) 0.85
Retracted Diagnostic and prognostic value of circulating miR-18a in the plasma of patients with gastric cancer. Tumour Biol (2014) 0.84
MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or Cholangiocarcinoma. PLoS One (2015) 0.84
Revealing editing and SNPs of microRNAs in colon tissues by analyzing high-throughput sequencing profiles of small RNAs. BMC Genomics (2014) 0.80
Is "liquid biopsy" useful for assessing HER2 status in gastric cancer? J Gastroenterol (2014) 0.80
Emerging platforms using liquid biopsy to detect EGFR mutations in lung cancer. Expert Rev Mol Diagn (2015) 0.79
Molecular screening of cancer-derived exosomes by surface plasmon resonance spectroscopy. Anal Bioanal Chem (2015) 0.78
Identification and characterization of EGF receptor in individual exosomes by fluorescence-activated vesicle sorting. J Extracell Vesicles (2016) 0.77
Comparisons of isomiR patterns and classification performance using the rank-based MANOVA and 10-fold cross-validation. Gene (2014) 0.76